Latest Content

Side Effects, Quality of Life Important to Consider in Breast Cancer Subset

September 29th 2024, 3:00pm

By Ashley Chan

Patients with HER2-positive metastatic breast cancer may consider related side effects and quality of life outcomes when choosing treatments.

Guiding Hope for Patients With Lung Cancer

September 28th 2024, 6:00pm

By Dr. Eric K. Singhi

Article

Two colleagues of Amy Wallace, an oncology nurse, nominated her for the Extraordinary Healer Award based on her care of patients with lung cancer.

Path to Previvor: My Journey from Diagnosis to Advocacy

September 28th 2024, 2:00pm

By Sara Kavanaugh

Article

My path as a previvor is far from being straightforward, but having available resources and support has helped me along the way.

FDA Approves Retevmo for Some With Medullary Thyroid Cancer

September 27th 2024, 7:48pm

By Darlene Dobkowski, MA

Article

The approval of Retevmo is for the treatment of adults and children aged 2 years and older with advanced or metastatic medullary thyroid cancer.

Prostate Cancer Questions Answered on Surgery, Side Effects and More

September 27th 2024, 7:00pm

By Alex Biese

Article

An expert answered CURE® readers’ questions on several aspects of a prostate cancer journey, including treatment options and sexual function.

There is Nothing Pink About Breast Cancer

September 27th 2024, 5:00pm

By Debbie Legault

Article

As a caregiver to my daughter who had breast cancer, pink takes on a new meaning for us — one I’m not quite a fan of.

Ann Wilson of Heart Returns After Chemo, Ryan Reynolds Visits Young Patient and More

September 27th 2024, 3:00pm

By Alex Biese

Article

From Ann Wilson’s return to Heart after chemotherapy to Ryan Reynolds visiting a fan with cancer, here’s what’s happening in the oncology space this week.

Supplemental New Drug Application Submitted for Nubeqa in Prostate Cancer Subset

September 27th 2024, 1:00pm

By Darlene Dobkowski, MA

Article

The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.

Cediranib Added to Lynparza Didn’t Improve Progression, Survival in Ovarian Cancer

September 26th 2024, 9:00pm

By Ashley Chan

Article

A Lynparza/cediranib combo had similar results versus standalone Lynparza among patients with relapsed platinum-sensitive ovarian cancer.

Palliative Care in Kidney Cancer More Than Just Relieving Symptoms

September 26th 2024, 7:00pm

By Ashley Chan

Article

Patients with kidney cancer who want more support during treatment can consider palliative care, whether it’s for symptoms or discussing goals and values.

3 Ways You Can Participate in Mesothelioma Awareness Day

September 26th 2024, 5:00pm

By Tamron Little

Article

As a cancer survivor, I’ve found three impactful ways to get involved in Mesothelioma Awareness Day to help make a difference.

Kidney Cancer Questions Answered, From Protein Intake to Clinical Trials

September 26th 2024, 3:00pm

By Alex Biese

Article

An expert provides answers to readers’ questions regarding different aspects of the kidney cancer experience, such as protein intake and clinical trials.